Section Arrow
Quote
HOLX.NASDAQ
- Hologic
Quotes are at least 15-min delayed:2024/05/19 14:37 EDT
Last
 75.02
+0.07 (+0.09%)
Day High 
75.285 
Prev. Close
74.95 
1-M High
79.75 
Volume 
1.45M 
Bid
74.15
Ask
77.49
Day Low
74.12 
Open
75.03 
1-M Low
74.53 
Market Cap 
17.49B 
Currency USD 
P/E 38.63 
%Yield 0 
10-SMA 75.64 
20-SMA 75.91 
50-SMA 76.26 
52-W High 82.45 
52-W Low 64.02 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.94/4.34
Enterprise Value
20.09B
Balance Sheet
Book Value Per Share
20.76
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
4.03B
Operating Revenue Per Share
17.30
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BAXBaxter International35.25+0.08+0.23%-- 
XRAYDENTSPLY SIRONA28.28-0.1-0.35%-- 
BDXBecton Dickinson and Co236.3-0.32-0.14%50.67PE
HOLXHologic75.02+0.07+0.09%38.63PE
WRBYWarby Parker16.53+0.39+2.42%-- 
Quotes are at least 15-min delayed：2024/05/19 14:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.